BaseHealth has tapped Jorge Velarde to serve as its CEO and president.
Cambridge Semantics said this week that it has signed a software integration agreement with ChemAxon that will allow it to integrate the latter's search and visualization capabilities into its Anzo software.
The Broad Institute has tapped Matthew Trunnell to serve as its new chief information officer.
The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.
Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.
Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.
In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.